BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 27219835)

  • 1. Pelvic floor muscles training to reduce symptoms and signs of vulvovaginal atrophy: a case study.
    Mercier J; Morin M; Lemieux MC; Reichetzer B; Khalifé S; Dumoulin C
    Menopause; 2016 Jul; 23(7):816-20. PubMed ID: 27219835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
    De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
    Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer.
    Juraskova I; Jarvis S; Mok K; Peate M; Meiser B; Cheah BC; Mireskandari S; Friedlander M
    J Sex Med; 2013 Oct; 10(10):2549-58. PubMed ID: 23635341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of vulvovaginal atrophy on women's quality of life from an Italian cohort of the EVES study.
    Nappi RE; Di Carlo C; Becorpi AM; Gambacciani M; De Seta F; Ribaldone R; Benedetto C; Paoletti AM;
    J Obstet Gynaecol; 2020 May; 40(4):512-519. PubMed ID: 31496326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease.
    Pérez-López FR; Phillips N; Vieira-Baptista P; Cohen-Sacher B; Fialho SCAV; Stockdale CK
    Gynecol Endocrinol; 2021 Aug; 37(8):746-752. PubMed ID: 34169794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of pulsed CO2 lasers for the treatment of vulvovaginal atrophy.
    Salvatore S; Athanasiou S; Candiani M
    Curr Opin Obstet Gynecol; 2015 Dec; 27(6):504-8. PubMed ID: 26536212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
    Kingsberg SA; Wysocki S; Magnus L; Krychman ML
    J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.
    DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J
    J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
    Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women.
    Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE;
    Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women.
    Nappi RE; Kotek M; Brešt'anský A; Giordan N; Tramentozzi E
    Climacteric; 2020 Oct; 23(5):519-524. PubMed ID: 32396754
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
    Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
    Pinkerton JV; Bushmakin AG; Komm BS; Abraham L
    Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
    Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
    Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study.
    Labrie F; Archer DF; Bouchard C; Girard G; Ayotte N; Gallagher JC; Cusan L; Baron M; Blouin F; Waldbaum AS; Koltun W; Portman DJ; Côté I; Lavoie L; Beauregard A; Labrie C; Martel C; Balser J; Moyneur É;
    Maturitas; 2015 May; 81(1):46-56. PubMed ID: 25771041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment.
    Villa P; Tagliaferri V; Amar ID; Cipolla C; Ingravalle F; Scambia G; Ricciardi W; Lanzone A
    Gynecol Endocrinol; 2020 Jun; 36(6):535-539. PubMed ID: 31847628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study.
    Nappi RE; Seracchioli R; Salvatore S; Cagnacci A; Di Paolantonio T; Busacca M;
    Gynecol Endocrinol; 2019 May; 35(5):453-459. PubMed ID: 30700188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.